BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ChamberMaster//Event Calendar 2.0//EN
METHOD:PUBLISH
X-PUBLISHED-TTL:P3D
REFRESH-INTERVAL:P3D
CALSCALE:GREGORIAN
BEGIN:VEVENT
DTSTART:20061020T130000Z
DTEND:20061020T200000Z
X-MICROSOFT-CDO-ALLDAYEVENT:FALSE
SUMMARY:Clemson Program to Highlight Upstate Biomedical Industry\, Entrepreneurial Activity
DESCRIPTION:The coating on millions of artificial hips\, the promise of aneurysms stunted with medication instead of surgery and powerful jolts of electricity from implanted defibrillators are examples of the biomedical innovations and products from Upstate South Carolina.\n\n\n\nThe Clemson University Research Foundation (CURF)\, in cooperation with the university's bioengineering department\, will present a program from 9 a.m. to 4 p.m.\, Friday\, Oct. 20\, at the Westin Poinsett in Greenville on the emerging biomedical industry in the state\, highlighting recent growth that builds on a long history of success in biomaterials and medical devices.\n\n\n\nClemson University's bioengineering department is internationally recognized for significant contributions in the field of biomaterials engineering. That reputation\, along with the university's expertise in technology transfer and support of biomedical start-up businesses\, led to the program\, which is in its second year. Last year\, the event attracted more than 150 attendees.\n\n\n\nExperts from the medical device and biomaterials industry representing national and international companies will speak on topics spanning the birth of biomedical ideas to clinical trials.\n\n\n\n Speakers and topics include:\n\n\n\nChristian Przirembel\, Clemson University vice president of research and economic development\, on Clemson's emphasis in biomedical sciences\n\n\nPamela Bunes\, president and CEO of Signallife\, an Upstate medical device company that produces breakthrough cardiac monitoring systems\n\n \nMichael Bolick\, president and CEO of Selah Technologies\, an emerging Upstate company focused on carbon-based nanotechnology useful in biomedical imaging\n\n \nTom Sander\, vice president of engineering and research at Pegasus Biologics\, on biomedical entrepreneurship\n\n \nScott Pletzer\, vice president of quality and engineering at Carzer Technologies\, on regulatory issues and the role of outsourcing\n\n\nDee Cross\, president of Equi-tox Pharmaceutical Research & Development and Clemson University emeritus faculty\, on professor-led technology start-ups\n\n \nMatt Gevaert\, technology commercialization officer of Clemson University Research Foundation\, on biomedical activities in the Upstate over the past year\n\n \nI.V. Hall\, vice president at Synthes\, with the keynote address on the orthopedic industry\n\n\n\nThe full agenda and registration information can be found online at www.clemson.edu/curf
X-ALT-DESC;FMTTYPE=text/html: The coating on millions of artificial hips\, the promise of aneurysms stunted with medication instead of surgery and powerful jolts of electricity from implanted defibrillators are examples of the biomedical innovations and products from Upstate South Carolina.<br><br>\n\nThe Clemson University Research Foundation (CURF)\, in cooperation with the university's bioengineering department\, will present a program from 9 a.m. to 4 p.m.\, Friday\, Oct. 20\, at the Westin Poinsett in Greenville on the emerging biomedical industry in the state\, highlighting recent growth that builds on a long history of success in biomaterials and medical devices.<br><br>\n\nClemson University's bioengineering department is internationally recognized for significant contributions in the field of biomaterials engineering. That reputation\, along with the university's expertise in technology transfer and support of biomedical start-up businesses\, led to the program\, which is in its second year. Last year\, the event attracted more than 150 attendees.<br><br>\n\nExperts from the medical device and biomaterials industry representing national and international companies will speak on topics spanning the birth of biomedical ideas to clinical trials.<br><br>\n\n Speakers and topics include:<br><br>\n\nChristian Przirembel\, Clemson University vice president of research and economic development\, on Clemson's emphasis in biomedical sciences<br><br>\nPamela Bunes\, president and CEO of Signallife\, an Upstate medical device company that produces breakthrough cardiac monitoring systems<br><br> \nMichael Bolick\, president and CEO of Selah Technologies\, an emerging Upstate company focused on carbon-based nanotechnology useful in biomedical imaging<br><br> \nTom Sander\, vice president of engineering and research at Pegasus Biologics\, on biomedical entrepreneurship<br><br> \nScott Pletzer\, vice president of quality and engineering at Carzer Technologies\, on regulatory issues and the role of outsourcing<br><br>\nDee Cross\, president of Equi-tox Pharmaceutical Research & Development and Clemson University emeritus faculty\, on professor-led technology start-ups<br><br> \nMatt Gevaert\, technology commercialization officer of Clemson University Research Foundation\, on biomedical activities in the Upstate over the past year<br><br> \nI.V. Hall\, vice president at Synthes\, with the keynote address on the orthopedic industry<br><br>\n\nThe full agenda and registration information can be found online at www.clemson.edu/curf \n\n \n\n\n\n\n\n\n
LOCATION:
UID:e.3091.464
SEQUENCE:3
DTSTAMP:20260516T233351Z
URL:https://www.andersonscchamber.com/events/details/clemson-program-to-highlight-upstate-biomedical-industry-entrepreneurial-activity-464
END:VEVENT

END:VCALENDAR